This inventor holds 1 USPTO granted patent and 17 published patent applications and 1 EPO patent. Top assignees: Illumina Corporation, Illumina Singapore Pte. Ltd.. Active years: 2025.
Company Filing History:
1 out of 1,214 
1 out of 33 Years Active: 2025
Title: The Innovations of Eric Brustad
Introduction
Eric Brustad is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid generation. His work has implications for various applications in genetic research and therapeutic development.
Latest Patents
Eric Brustad holds a patent for a method titled "Generating nucleic acids with modified bases using recombinant terminal deoxynucleotidyl transferase." This patent discloses methods for generating a single-stranded deoxyribonucleic acid (ssDNA) scaffold that comprises nucleotides with modified bases. The process utilizes a recombinant terminal deoxynucleotidyl transferase (TdT) that can have an amino acid sequence at least 80% identical to aTdT, including specific amino acid substitution mutations at functionally equivalent positions.
Career Highlights
Throughout his career, Eric has worked with notable companies such as Illumina Corporation and Illumina Singapore Pte. Ltd. His experience in these organizations has allowed him to contribute to cutting-edge research and development in the field of genomics.
Collaborations
Eric Brustad has collaborated with talented individuals in his field, including Saurabh Nirantar and Sergio Peisajovich. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Eric Brustad's contributions to biotechnology through his patent and career experiences highlight his role as a significant inventor in the field. His work continues to influence advancements in genetic research and applications.